Preclinical development of a balanced, tetravalent, live-attenuated vaccine against the four dengue virus serotypes
Ended Cooperative Agreement Awarded Last action
- Award ID
- W81XWH2220026
- Recipient
-
Codagenix Inc. UEI TEMNL437K2F1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $4,443,544
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Farmingdale, NY 11735, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $4,443,544 |
Quick answers
Who received award W81XWH2220026?
W81XWH2220026 was awarded to Codagenix Inc. by Defense Health Agency (Department of Defense) on August 1, 2022.
How much is award W81XWH2220026 worth?
$4,443,544 has been obligated on W81XWH2220026.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award